Somewhat Positive Press Coverage Somewhat Unlikely to Impact Great Basin Scientific (GBSN) Share Price

Media stories about Great Basin Scientific (NASDAQ:GBSN) have been trending somewhat positive this week, Accern Sentiment reports. The research firm identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Great Basin Scientific earned a news impact score of 0.13 on Accern’s scale. Accern also gave news articles about the medical research company an impact score of 46.3373649329104 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Here are some of the media stories that may have impacted Accern Sentiment’s analysis:

Shares of Great Basin Scientific (NASDAQ GBSN) opened at 0.0755 on Friday. Great Basin Scientific has a one year low of $0.07 and a one year high of $11,136,000.00. The company’s market capitalization is $149339.00. The firm’s 50-day moving average price is $0.21 and its 200 day moving average price is $1.57.

COPYRIGHT VIOLATION NOTICE: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact Great Basin Scientific (GBSN) Share Price” was originally posted by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.com-unik.info/2017/08/19/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-great-basin-scientific-gbsn-stock-price-updated-updated-updated.html.

About Great Basin Scientific

Great Basin Scientific, Inc is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C.

Insider Buying and Selling by Quarter for Great Basin Scientific (NASDAQ:GBSN)

What are top analysts saying about Great Basin Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Great Basin Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit